相关实验视频
Updated: Mar 10, 2026

10:36
Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
21.0K
预防性抗生素以预防神经障碍儿童的胸部感染:帕罗特RCT
Paul S McNamara1, Ashley Paul Jones2, Anne Chang3,4
1Department of Child Health (University of Liverpool), Institute in the Park, Alder Hey Children's Hospital, Liverpool, UK.
Health technology assessment (Winchester, England)
|March 9, 2026
概括
帕罗特试验研究了阿齐思罗米用于预防神经功能障碍儿童下呼吸道感染,但被提前停止. 由于功率不足,它无法确定阿齐思罗米.
科学领域:
- 儿科肺病学 儿科肺病学
- 临床试验 临床试验
- 传染性疾病 传染性疾病
背景情况:
- 患有神经功能障碍的儿童面临高风险的呼吸道疾病和频繁的下呼吸道感染.
- 预防性抗生素的使用正在增加,但对儿科患者有效性的证据有限.
- 帕罗特试验的目的是评估阿齐思罗米在预防这个脆弱群体下呼吸道感染方面的有效性.
研究的目的:
- 评估52周的阿齐思罗米辛预防与安慰剂在减少神经功能障碍儿童下呼吸道感染住院治疗的有效性.
- 提供关于预防性抗生素在儿科神经功能障碍的最佳使用的证据.
主要方法:
- 一个多中心,随机,双盲,安慰剂对照试验 (PARROT) 涉及90名3至17岁的神经障碍和呼吸系统症状的儿童.
- 参与者接受了52周的阿齐思罗米或安慰剂.
- 主要结局是52周期间患上下呼吸道感染住院儿童的比例.
主要成果:
- 由于COVID-19大流行,该试验被提前停止,导致样本大小小小于计划 (n=90).
- 由于下呼吸道感染而住院的病例率在阿齐思罗米辛组为36.7%,在安慰剂组为25.7%.
- 由于早期终止和样本规模较小,该研究没有足够的力量来得出关于阿齐思罗米有效性的最终结论.
结论:
- 由于早期关闭和不足,PARROT试验无法确定阿齐思罗米预防的有效性,以预防神经功能障碍儿童因下呼吸道感染住院治疗的情况.
- 住院患病率是这群人群未来试验的相关主要结果.
- 尽量减少家庭的试验负担对于未来在这个群体中的研究至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
343
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pneumonia V: Nursing management and Prevention
3.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Transmission-based Precautions II: Airborne and Protective Environment
2.1K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
595
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595
Transmission-based Precautions I: Contact, Enteric, and Droplets
4.9K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.9K
Pneumonia IV: Management
991
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
991

